| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/09/2023 | — | RBC Capital | Upgrades | Sector Perform → Outperform | |
| 01/03/2023 | — | Bernstein | Upgrades | Market Perform → Outperform | |
| 05/13/2022 | — | Jefferies | Downgrades | Buy → Hold | |
| 03/08/2022 | — | B of A Securities | Upgrades | Neutral → Buy | |
| 02/17/2022 | — | HSBC | Upgrades | Hold → Buy | |
| 01/26/2022 | — | B of A Securities | Downgrades | Buy → Neutral | |
| 01/07/2022 | — | Exane BNP Paribas | Downgrades | Neutral → Underperform | |
| 01/04/2022 | 16.66% | Bernstein | $35 → $36 | Downgrades | Outperform → Market Perform |
| 09/17/2021 | — | JP Morgan | Downgrades | Neutral → Underweight | |
| 09/16/2021 | — | Deutsche Bank | Downgrades | Buy → Hold | |
| 08/25/2021 | 10.17% | MKM Partners | → $34 | Initiates Coverage On | → Buy |
| 06/01/2021 | -9.27% | Bernstein | → $28 | Upgrades | Market Perform → Outperform |
| 04/30/2021 | — | Kepler Cheuvreux | Downgrades | Buy → Hold | |
| 03/12/2021 | — | Societe Generale | Upgrades | Hold → Buy | |
| 01/21/2021 | — | Jefferies | Initiates Coverage On | → Buy | |
| 09/11/2020 | — | RBC Capital | Upgrades | Sector Perform → Outperform | |
| 07/27/2020 | — | B of A Securities | Upgrades | Neutral → Buy | |
| 03/09/2020 | — | Bernstein | Downgrades | Outperform → Market Perform | |
| 09/27/2019 | — | DNB Markets | Downgrades | Buy → Hold | |
| 08/02/2019 | — | Goldman Sachs | Upgrades | Sell → Neutral | |
| 07/02/2019 | — | Bernstein | Upgrades | Market Perform → Outperform | |
| 02/14/2019 | — | Macquarie | Downgrades | Outperform → Neutral | |
| 02/11/2019 | — | Piper Sandler | Downgrades | Overweight → Neutral | |
| 12/14/2018 | — | Goldman Sachs | Downgrades | → Sell | |
| 12/11/2018 | — | B of A Securities | Downgrades | Buy → Neutral | |
| 11/29/2018 | — | JP Morgan | Downgrades | Neutral → Underweight | |
| 11/23/2018 | — | Barclays | Upgrades | Equal-Weight → Overweight | |
| 09/11/2018 | — | Berenberg | Initiates Coverage On | → Hold | |
| 09/11/2018 | — | Barclays | Upgrades | Underweight → Equal-Weight |
What is the target price for Equinor (EQNR)?
The latest price target for Equinor (NYSE: EQNR) was reported by RBC Capital on August 9, 2023. The analyst firm set a price target for $0.00 expecting EQNR to fall to within 12 months (a possible -100.00% downside). 2 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Equinor (EQNR)?
The latest analyst rating for Equinor (NYSE: EQNR) was provided by RBC Capital, and Equinor upgraded their outperform rating.
When is the next analyst rating going to be posted or updated for Equinor (EQNR)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Equinor, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Equinor was filed on August 9, 2023 so you should expect the next rating to be made available sometime around August 9, 2024.
Is the Analyst Rating Equinor (EQNR) correct?
While ratings are subjective and will change, the latest Equinor (EQNR) rating was a upgraded with a price target of $0.00 to $0.00. The current price Equinor (EQNR) is trading at is $30.86, which is out of the analyst's predicted range.